Profile | GDS4284 / 230917_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 7649.25 | 96 |
GSM687648 | Patient 402 control | 7713.9 | 96 |
GSM687653 | Patient 403 control | 6837.15 | 95 |
GSM687658 | Patient 404 control | 6669.87 | 95 |
GSM687663 | Patient 411 control | 5836.54 | 94 |
GSM687668 | Patient 422 control | 5279.15 | 94 |
GSM687673 | Patient 424 control | 6022.58 | 95 |
GSM687678 | Patient 425 control | 3799.75 | 91 |
GSM687683 | Patient 427 control | 4609.56 | 93 |
GSM687688 | Patient 428 control | 6603.08 | 95 |
GSM687695 | Patient 441 control | 4156.92 | 92 |
GSM687699 | Patient 443 control | 9639.51 | 97 |
GSM687704 | Patient 444 control | 6037.7 | 95 |
GSM687707 | Patient 448 control | 7721.55 | 96 |
GSM687712 | Patient 449 control | 5047.35 | 93 |
GSM687719 | Patient 450 control | 5718.9 | 94 |
GSM687724 | Patient 451 control | 6235.98 | 95 |
GSM687728 | Patient 452 control | 7427.43 | 96 |
GSM687646 | Patient 401 treated 24h | 6719.33 | 95 |
GSM687649 | Patient 402 treated 24h | 8828.69 | 97 |
GSM687665 | Patient 411 treated 24h | 6624.12 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 6368.04 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 7309.52 | 96 |
GSM687670 | Patient 422 treated 24h | 5411.08 | 94 |
GSM687671 | Patient 422 treated 4 weeks | 5578.97 | 94 |
GSM687654 | Patient 403 treated 24h | 6122.93 | 95 |
GSM687675 | Patient 424 treated 24h | 6454.04 | 95 |
GSM687685 | Patient 427 treated 24h | 4234.93 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 7361.43 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 5219.31 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 5026.18 | 93 |
GSM687692 | Patient 428 treated 4h | 7395.01 | 96 |
GSM687716 | Patient 449 treated 4h | 4858.15 | 93 |
GSM687722 | Patient 450 treated 4h | 6248.23 | 95 |
GSM687680 | Patient 425 treated 24h | 4221.42 | 92 |
GSM687690 | Patient 428 treated 24h | 8287.42 | 96 |
GSM687700 | Patient 443 treated 24h | 5451.59 | 94 |
GSM687705 | Patient 444 treated 24h | 3740.2 | 91 |
GSM687714 | Patient 449 treated 24h | 4816.58 | 93 |
GSM687721 | Patient 450 treated 24h | 5487.12 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 3471.42 | 90 |
GSM687694 | Patient 428 treated 4 weeks | 7165.24 | 96 |
GSM687702 | Patient 443 treated 4 weeks | 8876.62 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 4707.09 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 6642.29 | 95 |
GSM687661 | Patient 404 treated 4h | 7496.51 | 96 |
GSM687710 | Patient 448 treated 4h | 8352.62 | 96 |
GSM687726 | Patient 451 treated 4h | 5868.92 | 95 |
GSM687730 | Patient 452 treated 4h | 3430.97 | 91 |
GSM687660 | Patient 404 treated 24h | 5224.16 | 94 |
GSM687697 | Patient 441 treated 24h | 4037.77 | 92 |
GSM687709 | Patient 448 treated 24h | 6935.44 | 95 |
GSM687725 | Patient 451 treated 24h | 4799 | 93 |
GSM687729 | Patient 452 treated 24h | 6469.86 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 4515.69 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 4328.33 | 92 |